Jeremiah Pharms Jr.

Career StatsC-

Year	Team	GP	Sacks	Tkl	TFL
Career		31	2.0	45	6.5
2025		3	0.0	3	1
2024		16	2.0	33	5
2023		12

Current Contract

Contract Value Index (CVI)

Net of age, position, and term, Jeremiah Pharms Jr.'s deal earns a C Contract Value Index. At $1.005M AAV on a one-year deal, the contract itself carries minimal financial risk—he's occupying a depth slot at a position where replacement-level options are plentiful and cheap. His 2025 season production of 3 tackles across 3 games underscores his current standing as emergency roster filler rather than a contributor with upside; paired with his C- performance grade, there's little on-field justification for expecting meaningful impact. As a 29-year-old fourth-year player, Pharms is solidly in the veteran depth phase of his career, and the Patriots' recent signings of Travis Shaw at defensive tackle and their acquisition of high-impact talent at receiver and tackle suggest the organization views him as organizational ballast rather than part of the competitive core. The Contract Value Index reflects exactly what the mediaframing describes: a routine practice squad shuffle that maintains positional depth without representing any meaningful capital allocation or long-term bet on his trajectory. For a one-year, sub-$1.1M deal, there's no downside exposure—this is the kind of low-risk, low-reward transaction that defines NFL roster churn during the preseason and injury seasons.

Contracts in the Same Value Band

Other same-position deals the Contract Value Index also places in the C band — a quick read on where Jeremiah's contract sits relative to comparable money.

Performance Analysis

Per-game impact for Jeremiah Pharms Jr. pencils out to a C- performance grade. The 29-year-old fourth-year defensive tackle is operating squarely in replacement-level territory, a depth piece whose 2025 season production of 3 tackles across 3 games reflects minimal impact on a Patriots defense that has invested significantly in upgrading its front seven through recent acquisitions like Travis Shaw. His best showing came in tackle accumulation, though three stops across a three-game sample hardly establishes consistency or value beyond emergency fill-in duty. The core weakness is straightforward: Pharms lacks the snap count or production trajectory to earn meaningful minutes on a roster actively building around higher-caliber talent, leaving him vulnerable to displacement whenever organizational depth needs shift. As media coverage and fan sentiment both underscore, Pharms projects as the type of practice-squad-to-active-roster journeyman whose primary utility is availability during injury crises rather than planned defensive contributions. At this stage of his career, with a Patriots team targeting near-term contention and no statistical evidence of positional superiority, Pharms remains a cautionary example of NFL roster churn—the necessary but unremarkable depth management that separates franchise-focused rosters from pretenders.

How Jeremiah Compares at the Position

Jeremiah Pharms Jr. ranks 110th of 216 graded defensive tackles by performance. That slots Jeremiah between Anthony Campbell (C) just ahead and Naquan Jones (C-) just behind.

Fan Sentiment

Jeremiah Pharms Jr. represents the epitome of NFL roster churn, earning a C- sentiment grade as New England continues its standard practice squad shuffling at defensive tackle. The media coverage surrounding Pharms reflects routine organizational depth management rather than any meaningful investment in a future contributor, with multiple reports framing his elevations as procedural moves to maintain position group numbers. While Patriots beat writers have mentioned Super Bowl aspirations in passing, these references appear more aspirational than realistic given Pharms' current trajectory as emergency depth. Fans understand this type of roster manipulation as necessary but unremarkable—the kind of moves that happen weekly across the league when teams need warm bodies for practice and potential spot duty. The defensive tackle projects as a replacement-level player whose primary value lies in his availability during injury situations rather than any demonstrated on-field impact. His sentiment reflects the reality of being caught between practice squad limbo and active roster irrelevance, a position that generates little excitement or concern from either media or fanbase.